Evidence map›Paper›PMID 26196739›Full record

ArticlePLoS biology2015

The Orphan Nuclear Receptor TLX Is an Enhancer of STAT1-Mediated Transcription and Immunity to Toxoplasma gondii.

Daniel P Beiting, Shinya Hidano, Julie E Baggs, Jeanne M Geskes, Qun Fang, E John Wherry, Christopher A Hunter, David S Roos, Sara Cherry

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Forward Genetics in Apicomplexa Biology: The Host Side of the Story.Frontiers in cellular and infection microbiology · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Tuning up STAT1.PLoS biology · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Daniel P BeitingDepartment of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, United States of America.
Shinya HidanoDepartment of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, United States of America.
Julie E BaggsDepartment of Pharmacology and the Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Jeanne M GeskesDepartment of Pharmacology and the Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Qun FangDepartment of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, United States of America.
E John WherryDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Christopher A HunterDepartment of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, United States of America.
David S RoosDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Sara CherryDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
University of Pennsylvania · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
GENETIC DISSECTION OF TOXOPLASMA GONDIIR37AI028724 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROOS, DAVID S. · 1999 to 2008
$4.3M
The role of autophagy in innate anti-viral immunity in DrosophilaR01AI074951 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2007 to 2017
$4.2M
Dissecting the alphavirus entry receptor NRAMPR01AI095500 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2012 to 2015
$1.9M
CD8+ T cell memory and mucosal immunity to Toxoplamsa gondiiF32AI075846 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BEITING, DANIEL PATRICK · 2008 to 2010
$149k
NIAID NIH HHS F32 AI075846NIAID NIH HHS F32-AI075846NIAID NIH HHS R01 AI074951NIAID NIH HHS R01-AI074951NIAID NIH HHS R01 AI095500NIAID NIH HHS R37 AI028724NIAID NIH HHS R37-AI028724NIAID NIH HHS U54 AI057168NIAID NIH HHS U54-AI057168
6 · The paper itself

Abstract

The protozoan parasite, Toxoplasma, like many intracellular pathogens, suppresses interferon gamma (IFN-γ)-induced signal transducer and activator of transcription 1 (STAT1) activity. We exploited this well-defined host-pathogen interaction as the basis for a high-throughput screen, identifying nine transcription factors that enhance STAT1 function in the nucleus, including the orphan nuclear hormone receptor TLX. Expression profiling revealed that upon IFN-γ treatment TLX enhances the output of a subset of IFN-γ target genes, which we found is dependent on TLX binding at those loci. Moreover, infection of TLX deficient mice with the intracellular parasite Toxoplasma results in impaired production of the STAT1-dependent cytokine interleukin-12 by dendritic cells and increased parasite burden in the brain during chronic infection. These results demonstrate a previously unrecognized role for this orphan nuclear hormone receptor in regulating STAT1 signaling and host defense and reveal that STAT1 activity can be modulated in a context-specific manner by such "modifiers."

Indexed as

Gene Expression RegulationHost-Pathogen InteractionsAnimalsBrainCentral Nervous System InfectionsChemokine CXCL10Chemokine CXCL9Chronic DiseaseInterferon-gammaMice, Inbred CBAReceptors, Cytoplasmic and NuclearSTAT1 Transcription FactorToxoplasmaChemokine CXCL10Chemokine CXCL9Cxcl10 protein, mouseCxcl9 protein, mouseInterferon-gammaNr2e1 protein, mouseReceptors, Cytoplasmic and NuclearStat1 protein, mouseSTAT1 Transcription Factor

Identifiers

PMID26196739
PMCPMC4509904
OpenAlexW948570422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.